Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_2
1
33%
Ph not_applicable
1
33%
Ph phase_1
1
33%

Phase Distribution

1

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution3 total trials
Phase 1Safety & dosage
1(33.3%)
Phase 2Efficacy & side effects
1(33.3%)
N/ANon-phased studies
1(33.3%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(2)
Other(1)

Detailed Status

Completed2
unknown1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 11 (33.3%)
Phase 21 (33.3%)
N/A1 (33.3%)

Trials by Status

unknown133%
completed267%

Recent Activity

0 active trials
Showing 3 of 3
unknownphase_1

Repetitive Transcranial Stimulation (rTMS) for Resistant Depression in Adolescents

NCT01170520
completedphase_2

Repetitive Transcranial Stimulation (r-TMS) Treatment for Patients With Parkinson's Disease

NCT00625300
completednot_applicable

The Influence of Low Frequency Repetitive Transcranial Stimulation (r-TMS) Treatment on Motor and Cognitive Measurements in Patients With Parkinson's Disease

NCT00858546

Clinical Trials (3)

Showing 3 of 3 trials
NCT01170520Phase 1

Repetitive Transcranial Stimulation (rTMS) for Resistant Depression in Adolescents

Unknown
NCT00625300Phase 2

Repetitive Transcranial Stimulation (r-TMS) Treatment for Patients With Parkinson's Disease

Completed
NCT00858546Not Applicable

The Influence of Low Frequency Repetitive Transcranial Stimulation (r-TMS) Treatment on Motor and Cognitive Measurements in Patients With Parkinson's Disease

Completed

All 3 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
3